PARTICIPA

PARTICIPA

martes, 19 de octubre de 2021

Fatal breakthrough infection after anti-BCMA CAR-T therapy highlights suboptimal immune response to SARS-CoV-2 vaccination in myeloma patients

No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.